ProCE Banner Activity

CE / CME

Enhancing Care in Moderate to Severe Psoriasis: Patient Preference and Medication Adherence – Part 2

Video

Psoriasis is a chronic immune-mediated disorder affecting adult and pediatric patients. More than 1 in 5 patients with psoriasis have moderate to severe disease, which adversely affects health-related quality of life and causes substantial impairments in physical functioning and psychological well-being. Nevertheless, psoriasis is still frequently untreated or treated inadequately. In this webcast, dermatology experts discuss strategies for engaging patients in decision-making and improving adherence.

Nurse Practitioners: 0.50 Nursing contact hours, includes 0.50 hour of pharmacotherapy credit

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Physicians: Maximum of 0.50 AMA PRA Category 1 Credit

Released: January 06, 2023

Expiration: January 05, 2024

No longer available for credit.

Share

Faculty

Steven Feldman

Steven Feldman, MD, PhD

Professor of Dermatology, Pathology and Social Sciences & Health Policy
Wake Forest University School of Medicine
Winston-Salem, North Carolina

Kristine Kucera

Kristine Kucera, PA-C, MPAS, DHS

Physician Assistant
Bare Dermatology
Dallas, Texas
Adjunct Assistant Professor
UNT Health Science Center, PA Program
Ft. Worth, Texas

Melodie S. Young

Melodie S. Young, MSN, RN, ANP-C

Nurse Practitioner
Mindful Dermatology and Modern Research Associates
Dallas, Texas

Provided by

ProCE Banner
ProCE Banner

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation

Target Audience

Dermatologists and NPs, PAs, and nurses who practice in dermatology

Learning Objectives

After completing this activity, participants should be better able to:

  • Develop treatment regimens for patients with moderate to severe psoriasis based on treatment characteristics and patient preferences

Disclosure

All faculty and planners participating in continuing education activities sponsored by Partners for Advancing Clinical Education (PACE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Steven Feldman, MD, PhD: consultant/speaker: AbbVie, Accordant, Almirall, Alvotech, Amgen, Arcutis, Arena, Argenx, Biocon, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant, Forte, Helsinn, Janssen, Leo, Lilly, Mylan, Novartis, Pfizer, Samsung, Sanofi, Sun, UCB, vTv Therapeutics, Voluntis; researcher: Galderma, Janssen, Lilly, Pfizer, Regeneron; stock/stock options: Sensal Health.

Victoria Garcia-Albea, NP, DCNP: consultant/advisor/speaker: Sanofi-Genzyme.

Kristine Kucera, PA-C, MPAS, DHSc: consultant/advisor/speaker: AbbVie, Amgen, Beiersdorf, Bristol-Myers Squibb, Dermavant, Leo, Novartis, Sun, UCB.

Melodie S. Young, MSN, RN, ANP-C: consultant/advisor/speaker: AbbVie, Amgen, Arcutis, Boehringer Ingelheim, Janssen, Leo, Lilly, Novartis, UCB.

The planners and content peer reviewers from Partners for Advancing Clinical Education and Practicing Clinicians Exchange do not have any relevant financial relationships to disclose except Kristine Kucera, PA-C, MPAS, DHSc, and Victoria Garcia-Albea, NP, DCNP as noted above.

Instructions for Credit

Learners wishing to earn CE/CME credit must: 

  1. View the content in its entirety
  2. Relate the content material to the learning objectives 
  3. Complete evaluation form 

The estimated time to complete this activity is 0.50 hours.

Format

This program has been made available online.

Disclaimer

The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange, Clinical Care Options, Partners for Advancing Clinical Education, or any educational supporter.

Accreditation

Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
CCO designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team

ANCC Credit Designation
Nursing contact hours: 0.50, which includes 0.50 hours of pharmacology credit.

NP course advisor: Victoria Garcia-Albea, NP, DCNP, Lahey Hospital and Medical Center, Burlington, Massachusetts

AAPA Credit Designation
Joint AccreditationPartners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credit. Approval is valid until January 05, 2024. PAs should only claim credit commensurate with the extent of their participation.

PA course advisor: Kristine Kucera, PA-C, MPAS, DHSc, UT Southwestern Medical Center, Dallas Texas

IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credits for learning and change.